Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Pictet Group
AddedFeb 11, 2024
UpdatedJul 16, 2026
Pictet Group

Pictet Group

Operating

Pictet Group: A leading Swiss private bank offering wealth and asset management services.

Location
Geneva, Canton of Geneva, CH
Founded
1805
Firm
Compare
Portfolio
Employees
Website

Pictet Group is a Swiss multinational private bank and financial services company headquartered in Geneva. It primarily focuses on wealth management, asset management, and asset servicing for private clients and institutions. The firm invests across various stages, including Series A, B, D, E, G, and private equity rounds, with notable investments ranging from early to late stages. Pictet's investment size varies significantly, reflecting its flexibility in supporting diverse business needs.

The firm boasts a portfolio of high-profile companies such as Moderna, Chainalysis, and Inari Agriculture. Key partners and decision-makers at Pictet bring extensive expertise from their backgrounds in global finance. Pictet emphasizes an independent investment philosophy, ensuring alignment with client interests without external shareholder pressures. Additionally, the firm offers unique value-add services, including personalized attention and expert guidance, enhancing the growth and success of its portfolio companies.

Pictet Group - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments11
Current Portfolio Count6
Total Portfolio Exits2

Top Investment Stages

Series B3 (30.0%)
Series E3 (30.0%)
Series D2 (20.0%)
Private Equity1 (10.0%)
Series G1 (10.0%)

Stage Mix

Series B 30%Series E 30%Series D 20%Private Equity 10%Series G 10%

Concentration shown as share of disclosed investments by stage.

Recent Investments

RefleXion Medical logo

RefleXion Medical

Harbinger Health logo

Harbinger Health

Inari Agriculture logo

Inari Agriculture

Chainalysis logo

Chainalysis

Cellarity logo

Cellarity

Moderna logo

Moderna

Athena Art Finance logo

Athena Art Finance

CymaBay Therapeutics logo

CymaBay Therapeutics

Bluetrain.com logo

Bluetrain.com

Pictet Group - Similar Investment Firms

Pictet Alternative Advisors logo

Pictet Alternative Advisors

group.pictet

Partners Group logo

Partners Group

partnersgroup.com

Lombard Odier & Cie logo

Lombard Odier & Cie

lombardodier.com

UBS logo

UBS

ubs.com

PJT Partners logo

PJT Partners

pjtpartners.com

Julius Baer logo

Julius Baer

juliusbaer.com

Rothschild & Cie logo

Rothschild & Cie

Swiss Life Private Equity Partners logo

Swiss Life Private Equity Partners

swisslife.com

Vontobel logo

Vontobel

Societe Generale logo

Societe Generale

Pivot Investment Partners logo

Pivot Investment Partners

Pimco logo

Pimco

pimco.com

Picus Capital logo

Picus Capital

picuscap.com

Bpifrance logo

Bpifrance

bpifrance.com

Primwest logo

Primwest

primwest.com

Pictet Group - Classification

NAICS
  • 520000Finance and Insurance
  • 522000Credit Intermediation and Related Activities
  • 522100Depository Credit Intermediation
  • 522110Commercial Banking
SIC
  • 6000Depository Institutions
  • 6020Commercial Banks